Insights On Downstream Manufacturing
-
Future-Proof Your Bioprocess: The Science And Supply Chain Of Roche Enzymes
2/24/2026
High-purity trypsin and carboxypeptidase B enable critical protein processing in biopharma manufacturing. Learn how animal-free, GMP-grade production meets exacting quality standards for growing operations.
-
How To Choose The Appropriate Filter Material For Every Sample
2/24/2026
Membrane compatibility plays a crucial role in reliable sample filtration. Knowing how different filter materials interact helps prevent common workflow issues and supports efficient filtration.
-
Solutions For Lab Scale Sterile Filtration And Clarification
2/24/2026
Filtration strategies help maintain sample integrity by reducing particulates and controlling contaminants. Learn why choosing the right pore size supports consistent, reliable biological workflows.
-
Ultra-Low Cross-Linked Microgel Purification
2/24/2026
ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.
-
Enhancing Protein Recovery And Concentration
2/24/2026
Ultrafiltration offers a precise way to concentrate and purify proteins while removing smaller molecules. Learn how technique choice and membrane selection influence recovery, purity, and consistency.
-
Clearing The Path To Approval: Residual Reagent Control In AAV Gene Therapy
2/22/2026
Stricter regulatory expectations for AAV therapies demand robust control of residual transfection reagents, comprehensive documentation, and proactive quality strategies to avoid costly development delays.
-
Four Common Pitfalls To Avoid In UF/DF Setup And Scale-Up
2/18/2026
Learn how small UF/DF decisions can create major scale-up challenges, as well as practical ways to improve membrane selection, reduce manual operations, and boost PD–MSAT alignment.
-
A Comprehensive Blueprint For In Vitro Glycoengineering Adoption
2/13/2026
In vitro glycoengineering enables precise control of therapeutic protein glycosylation, streamlining product consistency and development through a phased, risk-managed integration after initial purification.
-
Reframing Residual DNA Testing: What It Is--And What It Isn't
2/11/2026
Residual host-cell DNA quantitation requires sensitive, well-validated analytical workflows to ensure accurate impurity control, process understanding, and regulatory compliance in complex biologics.
-
Levers To Optimize The IVT Reaction For Increased mRNA Yield
2/10/2026
Mastering IVT yield requires balancing magnesium and nucleotide ratios. Learn how specific buffers and pyrophosphatase optimize mRNA synthesis for scalable, high-quality therapeutic production.